0001522767-23-000111.txt : 20231030
0001522767-23-000111.hdr.sgml : 20231030
20231030172442
ACCESSION NUMBER: 0001522767-23-000111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231027
FILED AS OF DATE: 20231030
DATE AS OF CHANGE: 20231030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levine Jon R
CENTRAL INDEX KEY: 0001789645
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54433
FILM NUMBER: 231361581
MAIL ADDRESS:
STREET 1: C/O MARIMED INC.
STREET 2: 10 OCEANA WAY
CITY: NORWOOD
STATE: MA
ZIP: 02062
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MARIMED INC.
CENTRAL INDEX KEY: 0001522767
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 274672745
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 OCEANA WAY
STREET 2: 2ND FLOOR
CITY: NORWOOD
STATE: MA
ZIP: 02062
BUSINESS PHONE: 781-277-0007
MAIL ADDRESS:
STREET 1: 10 OCEANA WAY
STREET 2: 2ND FLOOR
CITY: NORWOOD
STATE: MA
ZIP: 02062
FORMER COMPANY:
FORMER CONFORMED NAME: WORLDS ONLINE INC.
DATE OF NAME CHANGE: 20110608
4
1
wk-form4_1698701072.xml
FORM 4
X0508
4
2023-10-27
0
0001522767
MARIMED INC.
MRMD
0001789645
Levine Jon R
C/O MARIMED INC.
10 OCEANA WAY
NORWOOD,
MA
02062
1
1
1
0
President and CEO
0
Common stock
2023-10-27
4
M
0
138889
A
20240472
D
Common stock
2023-10-27
4
S
0
41590
0.321
D
20198882
D
Common stock
6684640
I
By the Jon Levine Family Trust
Restricted Stock Units (RSU)
2023-10-27
4
M
0
138889
0
D
Common Stock, par value $.001 per share
138889
555555
D
RSUs convert to shares of common stock on a one-for-one basis.
Reflects shares of common stock sold pursuant to a Rule 10b5-1 instruction letter previously adopted by the Reporting Person prior to February 27, 2023 to satisfy tax withholding obligations in connection with the vesting of RSUs.
These shares are held in trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The RSUs vest over a three year period in equal one-sixth installments every six months following the October 27, 2022 grant date, in accordance with the terms of an award agreement, between the Issuer and the Reporting Person.
/s/ Jon R. Levine
2023-10-30